These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32912611)

  • 1. Science of superstimulation.
    Golla JP; Golla SK; Shelling AN
    Fertil Steril; 2020 Sep; 114(3):504-505. PubMed ID: 32912611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assisted reproduction and risks of superovulation].
    Seppälä M; Tiitinen A; Teramo K; Raivio K
    Duodecim; 1996; 112(4):245-7. PubMed ID: 10590636
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.
    Bagratee JS; Lockwood G; López Bernal A; Barlow DH; Ledger WL
    J Assist Reprod Genet; 1998 Feb; 15(2):65-9. PubMed ID: 9513843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study.
    Fisch B; Avrech OM; Pinkas H; Neri A; Rufas O; Ovadia J; Loumaye E
    J Assist Reprod Genet; 1995 Jan; 12(1):26-31. PubMed ID: 7580006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome.
    Tiitinen A; Husa LM; Tulppala M; Simberg N; Seppälä M
    Br J Obstet Gynaecol; 1995 Apr; 102(4):326-9. PubMed ID: 7612517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser vaporization of the ovarian surface in polycystic ovary disease results in reduced ovarian hyperstimulation and improved pregnancy rates.
    Fukaya T; Murakami T; Tamura M; Watanabe T; Terada Y; Yajima A
    Am J Obstet Gynecol; 1995 Jul; 173(1):119-25. PubMed ID: 7631668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?
    Caserta D; Lisi F; Marci R; Ciardo F; Fazi A; Lisi R; Moscarini M
    Gynecol Endocrinol; 2011 Nov; 27(11):862-6. PubMed ID: 21391759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three superovulation protocols with or without GnRH treatment at the time of artificial insemination on ovarian response and embryo quality in Thai native heifers.
    Chankitisakul V; Pitchayapipatkul J; Chuawongboon P; Rakwongrit D; Sakhong D; Boonkum W; Vongpralub T
    Trop Anim Health Prod; 2017 Mar; 49(3):633-639. PubMed ID: 28181120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superovulation and embryo transfer in wood bison (Bison bison athabascae).
    Toosi BM; Tribulo A; Lessard C; Mastromonaco GF; McCorkell RB; Adams GP
    Theriogenology; 2013 Sep; 80(5):542-51. PubMed ID: 23831114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superovulation with urinary human follicle-stimulating hormone: correlations with body mass index and body fat distribution.
    Zullo F; Di Carlo C; Pellicano M; Catizone C; Mastrantonio P; Nappi C
    Gynecol Endocrinol; 1996 Feb; 10(1):17-21. PubMed ID: 8737187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single epidural administration of follicle-stimulating hormone via caudal vertebrae on superstimulation for in vivo and in vitro embryo production in Japanese black cows.
    Sakaguchi K; Ideta A; Yanagawa Y; Nagano M; Katagiri S; Konishi M
    J Reprod Dev; 2018 Oct; 64(5):451-455. PubMed ID: 29910214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dominant follicle removal before superstimulation on follicular growth, ovulation and embryo production in Holstein cows.
    Kim IH; Son DS; Yeon SH; Choi SH; Park SB; Ryu IS; Suh GH; Lee DW; Lee CS; Lee HJ; Yoon JT
    Theriogenology; 2001 Mar; 55(4):937-45. PubMed ID: 11291916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy in women under 35 with elevated early follicular phase follicle-stimulating hormone levels. A report of five cases.
    Rose BI
    J Reprod Med; 1996 Mar; 41(3):201-4. PubMed ID: 8778423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization.
    Navot D; Rosenwaks Z
    J In Vitro Fert Embryo Transf; 1988 Feb; 5(1):3-13. PubMed ID: 3130451
    [No Abstract]   [Full Text] [Related]  

  • 17. Quintuplet pregnancy and third degree ovarian hyperstimulation despite withholding human chorionic gonadotrophin.
    Lipitz S; Ben-Rafael Z; Bider D; Shalev J; Mashiach S
    Hum Reprod; 1991 Nov; 6(10):1478-9. PubMed ID: 1770148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program.
    Chang MY; Chiang CH; Chiu TH; Hsieh TT; Soong YK
    J Assist Reprod Genet; 1998 Jan; 15(1):12-7. PubMed ID: 9493060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous ovarian hyperstimulation syndrome concomitant with spontaneous pregnancy in a woman with polycystic ovary disease.
    Zalel Y; Katz Z; Caspi B; Ben-Hur H; Dgani R; Insler V
    Am J Obstet Gynecol; 1992 Jul; 167(1):122-4. PubMed ID: 1442911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous Ovarian Hyperstimulation Syndrome in a Partial Molar Pregnancy With Early Onset Severe Pre-eclampsia at 15 Weeks Gestation.
    Davies MJ; Fletcher TL; Cox Bauer CM
    Mil Med; 2020 Sep; 185(9-10):e1836-e1839. PubMed ID: 32420602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.